160 related articles for article (PubMed ID: 21459435)
1. Immobilization of soluble complement receptor 1 on islets.
Luan NM; Teramura Y; Iwata H
Biomaterials; 2011 Jul; 32(20):4539-45. PubMed ID: 21459435
[TBL] [Abstract][Full Text] [Related]
2. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation.
Teramura Y; Iwata H
Transplantation; 2009 Sep; 88(5):624-30. PubMed ID: 19741458
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets.
Contreras JL; Xie D; Mays J; Smyth CA; Eckstein C; Rahemtulla FG; Young CJ; Anthony Thompson J; Bilbao G; Curiel DT; Eckhoff DE
Surgery; 2004 Sep; 136(3):537-47. PubMed ID: 15349100
[TBL] [Abstract][Full Text] [Related]
4. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid.
Chen H; Teramura Y; Iwata H
J Control Release; 2011 Mar; 150(2):229-34. PubMed ID: 21108976
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane.
Miura S; Teramura Y; Iwata H
Biomaterials; 2006 Dec; 27(34):5828-35. PubMed ID: 16919725
[TBL] [Abstract][Full Text] [Related]
6. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of instant blood-mediated inflammatory responses by co-immobilization of sCR1 and heparin on islets.
Luan NM; Iwata H
Biomaterials; 2013 Jul; 34(21):5019-24. PubMed ID: 23578554
[TBL] [Abstract][Full Text] [Related]
8. Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year.
Yun Lee D; Hee Nam J; Byun Y
Biomaterials; 2007 Apr; 28(11):1957-66. PubMed ID: 17188350
[TBL] [Abstract][Full Text] [Related]
9. Xenotransplantation of islets enclosed in agarose microcapsule carrying soluble complement receptor 1.
Luan NM; Iwata H
Biomaterials; 2012 Nov; 33(32):8075-81. PubMed ID: 22884812
[TBL] [Abstract][Full Text] [Related]
10. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers.
Teramura Y; Oommen OP; Olerud J; Hilborn J; Nilsson B
Biomaterials; 2013 Apr; 34(11):2683-93. PubMed ID: 23347835
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation.
Xie D; Smyth CA; Eckstein C; Bilbao G; Mays J; Eckhoff DE; Contreras JL
Biomaterials; 2005 Feb; 26(4):403-12. PubMed ID: 15275814
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of surface modification with poly(ethylene glycol) and immunosuppressants on repetitive pancreatic islet transplantation into antecedently sensitized rat.
Jeong JH; Yook S; Hwang JW; Jung MJ; Moon HT; Lee DY; Byun Y
Transplant Proc; 2013 Mar; 45(2):585-90. PubMed ID: 23267798
[TBL] [Abstract][Full Text] [Related]
13. Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets.
Luan NM; Teramura Y; Iwata H
Biomaterials; 2011 Sep; 32(27):6487-92. PubMed ID: 21663961
[TBL] [Abstract][Full Text] [Related]
14. Cell Surface Engineering for Regulation of Immune Reactions in Cell Therapy.
Teramura Y; Asif S; Ekdahl KN; Nilsson B
Adv Exp Med Biol; 2015; 865():189-209. PubMed ID: 26306451
[TBL] [Abstract][Full Text] [Related]
15. Islet surface modification with urokinase through DNA hybridization.
Takemoto N; Teramura Y; Iwata H
Bioconjug Chem; 2011 Apr; 22(4):673-8. PubMed ID: 21425812
[TBL] [Abstract][Full Text] [Related]
16. Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication.
Lee DY; Park SJ; Lee S; Nam JH; Byun Y
Tissue Eng; 2007 Aug; 13(8):2133-41. PubMed ID: 17516853
[TBL] [Abstract][Full Text] [Related]
17. Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation.
Luan NM; Teramura Y; Iwata H
Biomaterials; 2010 Dec; 31(34):8847-53. PubMed ID: 20739058
[TBL] [Abstract][Full Text] [Related]
18. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets.
Jang JY; Lee DY; Park SJ; Byun Y
Biomaterials; 2004 Aug; 25(17):3663-9. PubMed ID: 15020141
[TBL] [Abstract][Full Text] [Related]
19. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
[TBL] [Abstract][Full Text] [Related]
20. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane.
Teramura Y; Kaneda Y; Iwata H
Biomaterials; 2007 Nov; 28(32):4818-25. PubMed ID: 17698188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
